Keyphrases
Anergic
25%
Anergy
50%
Anti-miR
21%
Autoimmunity
12%
Autoreactive
12%
Autoreactive Lymphocyte
12%
Autoreactive T Cells
12%
Benign Prostatic Hyperplasia
7%
BPH-1
20%
CD4 T Cells
25%
Cell Migration
12%
Cell Motility
7%
Cell Surface
50%
Conserved Non-coding Elements
50%
DNA Methylation (DNAm)
12%
Epigenetic Modification
50%
Forkhead Box P3 (FOXP3)
50%
Foxp3 Expression
12%
FoxP3+
12%
Foxp3+ Tregs
12%
Healthy Tissue
12%
HT1080
19%
Immune Self
12%
In Vitro Wound Healing Assay
7%
Matrix Metalloproteinase Activity
71%
Mechanistic Aspects
12%
Metabolic Cues
50%
Metabolic Programming
12%
MicroRNA
56%
MiR-182
50%
MiR-183
14%
MiR-335
50%
MiR-96
7%
MT1-MMP
100%
Pathological Process
7%
Peripheral Immune Cells
12%
Phenotypic Characteristics
12%
Physiological Processes
7%
Protective Mechanism
12%
Regulatory T
12%
Regulatory T (Treg) Cells
50%
Self-tolerance
12%
Surface Expression
50%
Surface Membrane
50%
Thymus
12%
Treg
12%
Treg Differentiation
12%
Trichostatin A
14%
Trophic Control
12%
Tumor Cells
12%
Medicine and Dentistry
Autoimmunity
25%
Benign Prostatic Hyperplasia
14%
Cell Differentiation
25%
Cell Migration
7%
Cell Motility
7%
Cell Surface
50%
DNA Methylation
25%
Fibrosarcoma Cell
7%
HT1080
7%
Immunity
50%
Immunological Tolerance
25%
In Vitro
7%
Lymphocyte
25%
Matrix Metalloproteinase 14
50%
Messenger RNA
14%
microRNA
50%
microRNA 182
50%
Pathological Process
7%
Precursor
25%
Prostate Hypertrophy
7%
Prostatic Hyperplasia Cell Line
7%
Regulatory T Cell
50%
T Cell
25%
T-Helper Cell
50%
Thymus
25%
Trichostatin A
14%
Wound Healing
7%
Immunology and Microbiology
Autoimmunity
8%
Cell Differentiation
8%
Cell Membrane
16%
Cell Migration
40%
Cell Motility
7%
Cell Proliferation
16%
Cell Surface
100%
DNA Methylation
8%
Efferent Nerve
12%
Fibrosarcoma Cell
7%
Hypogastric Nerve
12%
Immune Tolerance
8%
Immunity
16%
Lymphocyte
8%
Pelvic Nerve
12%
Precursor
8%
Prostatic Hyperplasia Cell Line
7%
Regulatory T Cell
50%
T Cell
8%
T-Helper Cell
16%
Thymus
8%
Tumor Cell
33%
Wound Healing
16%
Wound Healing Assay
7%